Deals & Cases


On April 4, 2019, Santhera Pharmaceuticals Holding AG (SIX: SANN) announced that it had raised new liquid funds of up to CHF 22.1 m through a private placement of an aggregate of 500,000 new shares (resulting in gross proceeds of CHF 7.1 m), and earlier through a syndicated credit line facility in the amount of up to CHF 15 m.

Homburger acted as legal and tax counsel to Santhera. The Homburger team was led by partner Dieter Gericke (Corporate | M&A) and comprised partner Jürg Frick, counsel Eduard De Zordi (both Banking and Finance), partner Stefan Oesterhelt (Tax), associates Daniel Häusermann and Lorenzo Togni (both Corporate | M&A), as well as associate Simone Gloor and junior associate Kristof Reber (both Banking and Finance).